Flu antivirals prescribable at NHS expense

GPs can now prescribe antiviral medicines for the prophylaxis and treatment of influenza at NHS expense, in accordance with NICE guidance and the NHS Selected List Scheme (SLS).

Vaccines for the 2012/2013 season contain A/California/7/2009 as the H1N1-like virus strain, with A/Victoria/361/2011 as the H3N2-like component and B/Wisconsin/1/2010 as the influenza B component.
Vaccines for the 2012/2013 season contain A/California/7/2009 as the H1N1-like virus strain, with A/Victoria/361/2011 as the H3N2-like component and B/Wisconsin/1/2010 as the influenza B component.

The Department of Health decision was based on Health Protection Agency surveillance data showing an increase in flu activity.

Further information regarding at-risk groups and patients who are eligible for treatment at NHS expense with either Tamiflu (oseltamivir) or Relenza (zanamivir) can be found in Part XVIIIB of the Drug Tarrif.

GPs will be required to endorse prescriptions for the two influenza drugs with ‘SLS’.

Viroflu now available

In addition, the flu vaccine Viroflu (Janssen-Cilag) is now available for the current flu season.

View Viroflu drug record

View Tamiflu drug record

View Relenza drug record

Further information: Green Book – Chapter 19: Influenza

NICE guidance on the use of antiviral medicines for treatment of influenza.

NICE guidance on the use of antiviral medicines for prophylaxis of influenza.

Want news like this straight to your inbox?
Sign up for our bulletins

Read these next

Seasonal flu vaccines released

Seasonal flu vaccines released

Flu vaccines have been released for the 2013/14 flu...

Flu vaccines released for 2012/2013 season

Flu vaccines released for 2012/2013 season

Vaccines for the current flu season are now available.

Tamiflu oral suspension: concentration changed

Tamiflu oral suspension: concentration changed

The concentration of Tamiflu (oseltamivir) oral suspension...

Fluenz: first intranasal influenza vaccine

Fluenz: first intranasal influenza vaccine

Fluenz, a live attenuated vaccine, is licensed for...



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more